HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.

Abstract
Hodgkin lymphoma (HL) is composed of neoplastic Hodgkin and Reed-Sternberg cells in an inflammatory background. The neoplastic cells are derived from germinal center B cells that, in most cases, are infected by Epstein-Barr virus (EBV), which may play a role in tumorigenesis. Given that EBV-latent membrane protein 1 (LMP1) regulates autophagy in B cells, we explored the role of autophagy mediated by EBV or LMP1 in HL. We found that EBV-LMP1 transfection in HL cells induced a modest increase in autophagy signals, attenuated starvation-induced autophagic stress, and alleviated autophagy inhibition- or doxorubicin-induced cell death. LMP1 knockdown leads to decreased autophagy LC3 signals. A xenograft mouse model further showed that EBV infection significantly increased expression of the autophagy marker LC3 in HL cells. Clinically, LC3 was expressed in 15% (19/127) of HL samples, but was absent in all cases of nodular lymphocyte-predominant and lymphocyte-rich classic HL cases. Although expression of LC3 was not correlated with EBV status or clinical outcome, autophagic blockade effectively eradicated LMP1-positive HL xenografts with better efficacy than LMP1-negative HL xenografts. Collectively, these results suggest that EBV-LMP1 enhances autophagy and promotes the viability of HL cells. Autophagic inhibition may be a potential therapeutic strategy for treating patients with HL, especially EBV-positive cases.
AuthorsHui-Chen Lin, Yao Chang, Ruo-Yu Chen, Liang-Yi Hung, Paul Chih-Hsueh Chen, Ya-Ping Chen, L Jeffrey Medeiros, Po-Min Chiang, Kung-Chao Chang
JournalCancer science (Cancer Sci) Vol. 112 Issue 4 Pg. 1589-1602 (Apr 2021) ISSN: 1349-7006 [Electronic] England
PMID33525055 (Publication Type: Journal Article)
Copyright© 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Viral Matrix Proteins
  • Doxorubicin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Autophagy (genetics)
  • Cell Death (genetics)
  • Cell Line, Tumor
  • Cell Survival (genetics)
  • Child
  • Child, Preschool
  • Doxorubicin (therapeutic use)
  • Epstein-Barr Virus Infections (pathology, virology)
  • Female
  • Germinal Center (drug effects)
  • Herpesvirus 4, Human (genetics)
  • Heterografts
  • Hodgkin Disease (drug therapy, pathology, virology)
  • Humans
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Middle Aged
  • Up-Regulation (genetics)
  • Viral Matrix Proteins (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: